- Home
- ACFN vs ANTX Comparison
ACFN vs ANTX Comparison
Compare ACFN & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACFN | ANTX |
|---|---|---|
| Founded | 1986 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2M | 31.2M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | ACFN | ANTX |
|---|---|---|
| Price | $18.93 | $1.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 54.1K | ★ 129.7K |
| Earning Date | 03-05-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 473.47 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $12,630,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.15 | ★ N/A |
| Revenue Growth | ★ 30.11 | N/A |
| 52 Week Low | $12.42 | $1.00 |
| 52 Week High | $33.00 | $1.55 |
Technical Indicators
Market Signals| Indicator | ACFN | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.66 | 51.94 |
| Support Level | $19.60 | $1.14 |
| Resistance Level | $21.50 | $1.28 |
| Average True Range (ATR) | 1.58 | 0.11 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 55.08 | 57.16 |
Price Performance
Historical ComparisonAbout ACFN Acorn Energy Inc.
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.